Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6766368 | 0.90 | CA1 (0.39) | ALDH1A1LMNATP53TSHRCYP1A2 | |
| SCHEMBL283689 | 0.76 | — | — | |
| SCHEMBL167570 | 0.76 | — | — | |
| SCHEMBL47782 | 0.76 | — | — | |
| SCHEMBL8917948 | 0.76 | — | — | |
| SCHEMBL931042 | 0.76 | — | — | |
| Butyrolactone SCHEMBL1535022 | 0.74 | CA1 (0.44) | ALDH1A1LMNATP53TSHRCA1 | |
| SCHEMBL29825016 | 0.74 | PTPN1 (0.35) | LMNAPTPN1 | |
| SCHEMBL5156795 | 0.72 | — | — | |
| SCHEMBL5155772 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114206463-B | Lipid compounds and lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-118043306-A | Lipid compounds and lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-114391008-B | Lipid compounds and lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117580587-A | Coronavirus nucleic acid vaccine based on sequences derived from SARS-CoV-2 Omikovia strain | 苏州艾博生物科技有限公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-117460827-A | Nucleic acid vaccine for rabies | 苏州艾博生物科技有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-117202895-A | Lipid compounds and lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-117083291-A | Coronavirus nucleic acid vaccine based on sequences derived from SARS-CoV-2Delta strain | 苏州艾博生物科技有限公司 | 2023-11-17 | — | — | CN | disclosed |
| CN-117069785-A | Lipid compounds and lipid nanoparticle compositions | 中生复诺健生物科技(上海)有限公司 | 2023-11-17 | — | — | CN | disclosed |
| CN-117043343-A | Nucleic acid vaccine for mutant coronaviruses | 苏州艾博生物科技有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-117003658-A | Lipid Nanoparticle Compositions | 苏州艾博生物科技有限公司 | 2023-11-07 | — | — | CN | disclosed |
| EP-2515861-A2 | ACOUSTICALLY SENSITIVE DRUG DELIVERY PARTICLES COMPRISING LOW CONCENTRATIONS OF PHOSPHATIDYLETHANOLAMINE | Epitarget AS (NO) | 2012-10-31 | — | — | EP | disclosed |
| US-20120189689-A1 | ACOUSTICALLY SENSITIVE DRUG DELIVERY PARTICLES COMPRISING NON-LAMELLAR FORMING PHOSPHATIDYLCHOLINE | EPITARGET AS (NO) | 2012-07-26 | — | — | US | disclosed |
| US-20120121695-A1 | ACOUSTICALLY SENSITIVE DRUG DELIVERY PARTICLES COMPRISING NON-LAMELLAR FORMING PHOSPHATIDYLETHANOLAMINE | EPITARGET AS (NO) | 2012-05-17 | — | — | US | disclosed |
| EP-2440181-A2 | ACOUSTICALLY SENSITIVE DRUG DELIVERY PARTICLES COMPRISING PHOSPHATIDYLETHANOLAMINE | Epitarget AS (NO) | 2012-04-18 | — | — | EP | disclosed |
| EP-2440176-A2 | ACOUSTICALLY SENSITIVE DRUG DELIVERY PARTICLES COMPRISING NON-LAMELLAR FORMING PHOSPHATIDYLCHOLINE | Epitarget AS (NO) | 2012-04-18 | — | — | EP | disclosed |
| WO-2011078695-A2 | ACOUSTICALLY SENSITIVE DRUG DELIVERY PARTICLES COMPRISING LOW CONCENTRATIONS OF PHOSPHATIDYLETHANOLAMINE | EPITARGET AS (NO) | 2011-06-30 | — | — | WO | disclosed |
| WO-2010143969-A2 | ACOUSTICALLY SENSITIVE DRUG DELIVERY PARTICLES COMPRISING NON-LAMELLAR FORMING PHOSPHATIDYLETHANOLAMINE | EPITARGET AS (NO) | 2010-12-16 | — | — | WO | disclosed |
| WO-2010143970-A2 | ACOUSTICALLY SENSITIVE DRUG DELIVERY PARTICLES COMPRISING NON-LAMELLAR FORMING PHOSPHATIDYLCHOLINE | EPITARGET AS (NO) | 2010-12-16 | — | — | WO | disclosed |
| WO-2010143972-A2 | ACOUSTICALLY SENSITIVE DRUG DELIVERY PARTICLES COMPRISING NON-LAMELLAR FORMING LIPIDS | EPITARGET AS (NO) | 2010-12-16 | — | — | WO | disclosed |
| WO-1992007959-A1 | HOMOGENEOUS MEMBRANE LYTIC IMMUNOASSAY METHOD UTILIZING CONTACT SENSITIVE LIPOSOME FORMULATIONS | BIOWHITTAKER INC. (US) | 1992-05-14 | — | — | WO | disclosed |